Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Black Diamond Therapeutics, Inc. | 250,000 | reported | 21 Jan 2026 | tx 53+1,196,353−269,641 |
| MPM ACQUISITION CORP | 17,944 | reported | 22 Feb 2019 | tx 6+254,278 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 Jan 2026 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 250,000 | 0.00 USD | deriv |
| 30 Jan 2025 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 75,000 | 0.00 USD | |
| 30 Jan 2025 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 175,000 | 0.00 USD | deriv |
| 14 Feb 2024 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 200,000 | 0.00 USD | deriv |
| 13 Feb 2023 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 200,000 | 0.00 USD | deriv |
| 15 Feb 2022 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 90,000 | 0.00 USD | deriv |
| 12 May 2021 | EXERCISE | Black Diamond Therapeutics, Inc. | 4,078 | 3.20 USD | |
| 12 May 2021 | SALE | Black Diamond Therapeutics, Inc. | 1,161 | 26.11 USD | |
| 12 May 2021 | SALE | Black Diamond Therapeutics, Inc. | 2,566 | 27.90 USD | |
| 12 May 2021 | SALE | Black Diamond Therapeutics, Inc. | 351 | 28.20 USD | |
| 12 May 2021 | EXERCISE | Black Diamond Therapeutics, Inc. | 4,078 | 0.00 USD | deriv |
| 12 Apr 2021 | EXERCISE | Black Diamond Therapeutics, Inc. | 4,078 | 3.20 USD | |
| 12 Apr 2021 | SALE | Black Diamond Therapeutics, Inc. | 4,078 | 25.00 USD | |
| 12 Apr 2021 | EXERCISE | Black Diamond Therapeutics, Inc. | 179,915 | 0.00 USD | deriv |
| 12 Mar 2021 | EXERCISE | Black Diamond Therapeutics, Inc. | 4,078 | 3.20 USD | |
| 12 Mar 2021 | SALE | Black Diamond Therapeutics, Inc. | 4,078 | 26.36 USD | |
| 12 Mar 2021 | EXERCISE | Black Diamond Therapeutics, Inc. | 4,078 | 0.00 USD | deriv |
| 17 Feb 2021 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 12 Feb 2021 | EXERCISE | Black Diamond Therapeutics, Inc. | 4,078 | 3.20 USD | |
| 12 Feb 2021 | SALE | Black Diamond Therapeutics, Inc. | 3,771 | 27.19 USD | |
| 12 Feb 2021 | SALE | Black Diamond Therapeutics, Inc. | 307 | 27.66 USD | |
| 12 Feb 2021 | EXERCISE | Black Diamond Therapeutics, Inc. | 4,078 | 0.00 USD | deriv |
| 12 Jan 2021 | EXERCISE | Black Diamond Therapeutics, Inc. | 4,078 | 3.20 USD | |
| 12 Jan 2021 | EXERCISE | Black Diamond Therapeutics, Inc. | 7,500 | 10.86 USD | |
| 12 Jan 2021 | SALE | Black Diamond Therapeutics, Inc. | 2,048 | 29.92 USD |
1 purchase reported after at least 12 months of silence — most recent on 03 Feb 2020.